Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Chimeric antigen receptor T cells targeting CD79b show efficacy in lymphoma with or without co-targeting CD19.

Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Haaber J, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV.

Clin Cancer Res. 2019 Aug 22. pii: clincanres.1337.2019. doi: 10.1158/1078-0432.CCR-19-1337. [Epub ahead of print]

PMID:
31439577
2.

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report.

Iversen KF, Holdgaard PC, Preiss B, Nyvold CG, Plesner T.

Haematologica. 2019 Sep;104(9):e432-e433. doi: 10.3324/haematol.2018.214635. Epub 2019 Apr 11. No abstract available.

3.

Sensitive quantification of the intronless SOX11 mRNA from lymph nodes biopsies in mantle cell lymphoma.

Nielsen PI, Hansen SV, Møller MB, Kristensen TK, Cédile O, Hansen MC, Ebbesen LH, Haaber J, Abildgaard N, Nyvold CG.

Leuk Res. 2019 Mar;78:1-2. doi: 10.1016/j.leukres.2019.01.001. Epub 2019 Jan 3. No abstract available.

PMID:
30640013
4.

Chronic lymphocytic leukemia patients with heterogeneously or fully methylated LPL promotor display longer time to treatment.

Daugaard I, Hussmann D, Kristensen L, Kristensen T, Kjeldsen TE, Nyvold CG, Larsen TS, Møller MB, Hansen LL, Wojdacz TK.

Epigenomics. 2018 Sep;10(9):1155-1166. doi: 10.2217/epi-2018-0020. Epub 2018 Sep 5.

PMID:
30182737
5.

Differential expression levels and methylation status of ROBO1 in mantle cell lymphoma and chronic lymphocytic leukaemia.

Appe AJ, Aggerholm A, Hansen MC, Ebbesen LH, Hokland P, Bentzen HHN, Nyvold CG.

Int J Lab Hematol. 2017 Jun;39(3):e70-e73. doi: 10.1111/ijlh.12615. Epub 2016 Dec 22. No abstract available.

PMID:
28004534
6.

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research.

Hansen MC, Nederby L, Roug A, Villesen P, Kjeldsen E, Nyvold CG, Hokland P.

MethodsX. 2015 Mar 12;2:145-53. doi: 10.1016/j.mex.2015.03.003. eCollection 2015.

7.

Nature and nurture: a case of transcending haematological pre-malignancies in a pair of monozygotic twins adding possible clues on the pathogenesis of B-cell proliferations.

Hansen MC, Nyvold CG, Roug AS, Kjeldsen E, Villesen P, Nederby L, Hokland P.

Br J Haematol. 2015 May;169(3):391-400. doi: 10.1111/bjh.13305. Epub 2015 Mar 5.

PMID:
25752595
8.

Critical methodological factors in diagnosing minimal residual disease in hematological malignancies using quantitative PCR.

Nyvold CG.

Expert Rev Mol Diagn. 2015 May;15(5):581-4. doi: 10.1586/14737159.2015.1014341. Epub 2015 Feb 12.

PMID:
25676837
9.

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma?

Simonsen AT, Schou M, Sørensen CD, Bentzen HH, Nyvold CG.

Leuk Lymphoma. 2015;56(9):2724-7. doi: 10.3109/10428194.2015.1004672. Epub 2015 Feb 11. No abstract available.

PMID:
25629991
10.

Sensitive ligand-based protein quantification using immuno-PCR: A critical review of single-probe and proximity ligation assays.

Hansen MC, Nederby L, Henriksen MO, Hansen M, Nyvold CG.

Biotechniques. 2014 May;56(5):217-28.

11.

Cell sorting enables interphase fluorescence in situ hybridization detection of low BCR-ABL1 producing stem cells in chronic myeloid leukaemia patients beyond deep molecular remission.

van Kooten Niekerk PB, Petersen CC, Nyvold CG, Ommen HB, Roug AS, Nederby L, Hokland P, Kjeldsen E.

Br J Haematol. 2014 Jan;164(1):53-60. doi: 10.1111/bjh.12589.

PMID:
24903628
12.

SOX11 as a minimal residual disease marker for Mantle cell lymphoma.

Simonsen AT, Sørensen CD, Ebbesen LH, Bødker JS, Bentzen HH, Nyvold CG.

Leuk Res. 2014 Aug;38(8):918-24. doi: 10.1016/j.leukres.2014.04.007. Epub 2014 Apr 28.

PMID:
24878000
13.

Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.

Sørensen CD, Jørgensen JM, Nederby L, Hokland P, Nyvold CG.

J Immunol Methods. 2014 Apr;406:131-6. doi: 10.1016/j.jim.2014.03.004. Epub 2014 Mar 13.

PMID:
24631717
14.

Delineation of known and new transcript variants of the SETMAR (Metnase) gene and the expression profile in hematologic neoplasms.

Jeyaratnam DC, Baduin BS, Hansen MC, Hansen M, Jørgensen JM, Aggerholm A, Ommen HB, Hokland P, Nyvold CG.

Exp Hematol. 2014 Jun;42(6):448-56.e4. doi: 10.1016/j.exphem.2014.02.005. Epub 2014 Mar 4.

PMID:
24607956
15.

hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia.

Roug AS, Larsen HØ, Nederby L, Just T, Brown G, Nyvold CG, Ommen HB, Hokland P.

Br J Haematol. 2014 Jan;164(2):212-22. doi: 10.1111/bjh.12614. Epub 2013 Oct 24.

PMID:
24152218
16.

Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia.

Silkjaer T, Nyvold CG, Juhl-Christensen C, Hokland P, Nørgaard JM.

Eur J Haematol. 2013 Oct;91(4):295-303. doi: 10.1111/ejh.12166. Epub 2013 Aug 20.

PMID:
23826975
17.

A novel RT-qPCR assay for quantification of the MLL-MLLT3 fusion transcript in acute myeloid leukaemia.

Abildgaard L, Ommen HB, Lausen B, Hasle H, Nyvold CG.

Eur J Haematol. 2013 Nov;91(5):394-8. doi: 10.1111/ejh.12156. Epub 2013 Oct 1.

PMID:
23772754
18.

Chronic myeloid leukaemia presenting with isolated thrombocythaemia, a case revealing its stem cell biology.

van Kooten Niekerk PB, Roug AS, Petersen CC, Ommen HB, Kjeldsen E, Bendix K, Nyvold CG, Nederby L, Hokland P.

Br J Haematol. 2013 Jul;162(1):141-4. doi: 10.1111/bjh.12339. Epub 2013 Apr 18. No abstract available.

PMID:
23593974
19.

Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia.

Silkjaer T, Nørgaard JM, Aggerholm A, Ebbesen LH, Kjeldsen E, Hokland P, Nyvold CG.

Eur J Haematol. 2013 May;90(5):385-96. doi: 10.1111/ejh.12090. Epub 2013 Mar 22.

PMID:
23444869
20.

A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.

Hamborg KH, Bentzen HH, Grubach L, Hokland P, Nyvold CG.

Eur J Haematol. 2012 Nov;89(5):385-94. doi: 10.1111/j.1600-0609.2012.01837.x. Epub 2012 Aug 21. Review.

PMID:
22827557
21.

Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation.

Hokland P, Ommen HB, Nyvold CG, Roug AS.

Br J Haematol. 2012 Sep;158(5):569-80. doi: 10.1111/j.1365-2141.2012.09203.x. Epub 2012 Jun 28. Review.

PMID:
22738609
22.

Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.

Tan AY, Wong SQ, Nyvold CG, Carney DA, Wei A, Seymour JF, Hokland P, Westerman, Dobrovic A.

Leuk Lymphoma. 2012 Jun;53(6):1225-9. doi: 10.3109/10428194.2011.645817. Epub 2012 Jan 13. No abstract available.

PMID:
22132874
23.

A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.

Roug AS, Nyvold CG, Juhl-Christensen C, Christensen M, Schnittger S, Hokland P.

Eur J Haematol. 2011 Nov;87(5):461-3. doi: 10.1111/j.1600-0609.2011.01669.x. Epub 2011 Aug 11.

PMID:
21689158
24.

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Østergaard M, Nyvold CG, Jovanovic JV, Andersen MT, Kairisto V, Morgan YG, Tobal K, Pallisgaard N, Ozbek U, Pfeifer H, Schnittger S, Grubach L, Larsen JK, Grimwade D, Hokland P.

Leukemia. 2011 Jul;25(7):1168-73. doi: 10.1038/leu.2011.69. Epub 2011 Apr 15.

PMID:
21494256
25.

The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML.

Zangenberg M, Grubach L, Aggerholm A, Silkjaer T, Juhl-Christensen C, Nyvold CG, Kjeldsen E, Ommen HB, Hokland P.

Eur J Haematol. 2009 Nov;83(5):439-48. doi: 10.1111/j.1600-0609.2009.01309.x. Epub 2009 Jun 25.

PMID:
19563517
26.

[Minimal residual disease in malignant diseases of the blood II. Translation and therapeutic consequences].

Hokland P, Ommen HB, Nyvold CG, Stentoft J, Braendstrup K, Andersen BL, Mikkelsen LS, Ostergaard M.

Ugeskr Laeger. 2009 Jan 19;171(4):232-5. Danish.

PMID:
19174038
27.

[Minimal residual disease in malignant diseases of the blood I. Background and pre-clinical validation].

Hokland P, Nyvold CG, Stentoft J, Ommen HB, Ebbesen LH, Braendstrup K, Andersen BL, Mikkelsen LS, Ostergaard M.

Ugeskr Laeger. 2009 Jan 19;171(4):229-31. Danish.

PMID:
19174037
28.

Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.

Juhl-Christensen C, Bomberg M, Melsvik D, Hokland P, Nyvold CG.

Eur J Haematol. 2008 Oct;81(4):273-80. doi: 10.1111/j.1600-0609.2008.01117.x. Epub 2008 Jul 8.

PMID:
18616509
29.

Infectious complications after chemotherapy and stem cell transplantation in multiple myeloma: implications of Fc gamma receptor and myeloperoxidase promoter polymorphisms.

Mølle I, Ostergaard M, Melsvik D, Nyvold CG.

Leuk Lymphoma. 2008 Jun;49(6):1116-22. doi: 10.1080/10428190802074585.

PMID:
18452102
30.

Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.

Ommen HB, Nyvold CG, Braendstrup K, Andersen BL, Ommen IB, Hasle H, Hokland P, Ostergaard M.

Br J Haematol. 2008 Jun;141(6):782-91. doi: 10.1111/j.1365-2141.2008.07132.x. Epub 2008 Apr 10.

PMID:
18410450
31.

Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories.

Müller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T, Ernst T, Lauber S, Kruth J, Hehlmann R, Hochhaus A; European LeukemiaNet.

Leukemia. 2008 Jan;22(1):96-102. Epub 2007 Oct 18.

PMID:
17943168
33.

Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications.

Nyvold CG, Stentoft J, Braendstrup K, Melsvik D, Moestrup SK, Juhl-Christensen C, Hasle H, Hokland P.

Leukemia. 2006 Nov;20(11):2051-4. Epub 2006 Sep 21. No abstract available.

PMID:
16990770
34.

Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.

Rethmeier A, Aggerholm A, Olesen LH, Juhl-Christensen C, Nyvold CG, Guldberg P, Hokland P.

Br J Haematol. 2006 May;133(3):276-83.

PMID:
16643429
35.

Interleukin-21 mRNA expression during virus infections.

Holm C, Nyvold CG, Paludan SR, Thomsen AR, Hokland M.

Cytokine. 2006 Jan 7;33(1):41-5. Epub 2006 Jan 5. Erratum in: Cytokine. 2006 Jul;35(1-2):107. Plaudan, Søren R [corrected to Paludan, Søren R].

PMID:
16406655
36.

Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling.

Olesen LH, Aggerholm A, Andersen BL, Nyvold CG, Guldberg P, Nørgaard JM, Hokland P.

Br J Haematol. 2005 Nov;131(4):457-67.

PMID:
16281935
38.

WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.

Hasle H, Lund B, Nyvold CG, Hokland P, Østergaard M.

Leuk Res. 2006 May;30(5):543-6. Epub 2005 Oct 19.

PMID:
16242775
39.

Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.

Olesen LH, Nyvold CG, Aggerholm A, Nørgaard JM, Guldberg P, Hokland P.

Eur J Haematol. 2005 Sep;75(3):185-92.

PMID:
16104873
40.

Erythropoietin receptor defect: a cause of primary polycythaemia.

Petersen KB, Hokland P, Petersen GB, Nyvold CG.

Br J Haematol. 2004 May;125(4):537-8. Review. No abstract available. Erratum in: Br J Haematol. 2004 Oct;127(2):240. Brorson Petersen, K [corrected to Petersen, KB]; Bruun Petersen, G [corrected to Petersen, GB]; [Guldborg Nyvold , C [corrected to Nyvold, CG].

PMID:
15142125

Supplemental Content

Loading ...
Support Center